Skip to Content

Canopy Growth Corp

CGC: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$9.40QccmFnpqp

Canopy's Financial Performance Improving, but Repeated Dilution Continues to Destroy Value

Business Strategy and Outlook

Canopy Growth grows and sells cannabis products primarily in Canada, which accounts for roughly 60% of sales. Unfortunately, the Canadian market is overloaded with too many licensed producers, leading to tough price competition and a stubbornly robust illicit market, so Canopy has yet to reach profitability. We forecast mid-single-digit growth over the next decade for the Canadian market, driven by the conversion of illicit consumers into the legal market. We expect competition to ease as continued industry losses drive consolidation.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CGC so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center